The GLP-1 Revolution: How Appetite-Suppressing Drugs Are Changing Diets and Disrupting the Food Industry From fewer chips to more yogurt, discover how Ozempic and Wegovy are reshaping grocery carts, dining habits, and consumer behavior
On the horizon is retatrutide
This was the partners second try for FDA approval after the regulator rejected Ngenlas first bid in January 2022
While it shows promise for cognitive enhancement and neuroprotection, the lack of extensive research means that some potential risks may remain unknown
Not only the regain in body mass will be significant, she is unlikely to be able to restore her muscle mass, even with lifelong, heavy, daily resistance training, and dramatic increase in protein consumption